Yael Nisgav Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

1/2021	Activated Protein C (APC) and 3K3A-APC-Induced Regression of Choroidal Neovascularization (CNV) Is Accompanied by Vascular Endothelial Growth Factor (VEGF) Reduction.
1/2019	Comparison of Subconjunctival Aflibercept and Betamethasone for the Treatment of Formed Corneal Neovascularization in a Rabbit Model.
7/2016	Efficacy of Subconjunctival Aflibercept Versus Bevacizumab for Prevention of Corneal Neovascularization in a Rat Model.
1/2016	Bevacizumab clearance through the iridocorneal angle following intravitreal injection in a rat model.
12/2010	Enhancement of angiogenic potential of endothelial cells by contact with retinal pigment epithelial cells in a model simulating pathological conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yael Nisgav Research Topics

Disease

8	Choroidal Neovascularization 06/2023 - 12/2010
4	Inflammation (Inflammations) 11/2022 - 01/2016
4	Corneal Neovascularization 01/2019 - 01/2016
3	Hemorrhage 06/2023 - 01/2021
3	Chemical Burns (Chemical Burn) 01/2019 - 01/2016
2	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2020 - 01/2017
2	Hypoxia (Hypoxemia) 02/2019 - 12/2010
2	Rupture 11/2017 - 01/2016
2	Glaucoma 08/2007 - 06/2006
1	Uveitis 11/2022
1	Retinal Detachment (Retinal Detachments) 08/2020
1	Retinal Diseases 01/2017
1	Pathologic Neovascularization 01/2016
1	Ocular Hypertension (Glaucoma, Suspect) 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2016

Drug/Important Bio-Agent (IBA)

5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 12/2010
3	AnticoagulantsIBA 06/2023 - 01/2021
3	Retinaldehyde (Retinal)IBA 11/2022 - 01/2019
3	afliberceptIBA 01/2019 - 01/2016
2	InflammasomesIBA 06/2023 - 11/2022
2	3K3A-APC proteinIBA 06/2023 - 11/2022
2	Protein CIBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 08/2020 - 02/2019
2	Histone Deacetylase InhibitorsIBA 02/2019 - 07/2017
2	Bevacizumab (Avastin)FDA Link 07/2016 - 01/2016
2	Retinal Pigments (Pigments, Visual)IBA 01/2016 - 12/2010
1	LipopolysaccharidesIBA 11/2022
1	Endothelial Growth FactorsIBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Betamethasone (Celestone)FDA Link 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	diethoxyphosphoryloxymethyl butanoateIBA 07/2017
1	antithrombin III-protease complexIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	CytokinesIBA 01/2017
1	TelluriumIBA 01/2016
1	Apolipoprotein E4IBA 01/2016
1	Interleukin-8 (Interleukin 8)IBA 01/2016
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 08/2007
1	CaspasesIBA 08/2007
1	Phosphotransferases (Kinase)IBA 08/2007
1	Messenger RNA (mRNA)IBA 06/2006

Therapy/Procedure

2	Lasers (Laser) 11/2017 - 08/2007
2	Light Coagulation 01/2016 - 08/2007
1	Vitrectomy 08/2020
1	Aftercare (After-Treatment) 01/2019
1	Semiconductor Lasers 01/2016